This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Learn effective ways to generate fast income that can help you meet your financial goals. Start boosting your earnings now!
17,300 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
A 25-year-old CEO leads a bold new player into federal banking with an OCC charter and a $40 million funding round, s...
As May 14 approaches, investors weigh growth momentum, profitability, and AI competition around figma's next earnings...
A CRMLS survey of agents who closed deals this year shows broad backing for the MLS Clear Cooperation policy, with st...
Former Goldman Sachs CEO Lloyd Blankfein warns that AI operates with speed but limited verifiability, a risk that cou...
A viral claim has sparked headlines: a bitcoin owner claims claude helped recover a lost wallet and netted $400K in B...
Kraken is shifting its wrapped bitcoin tech to Chainlink amid a broader LayerZero exodus. This move could alter cross...
Binance updates this week are reshaping liquidity for smaller tokens while Ripple (XRP) posts a solid weekly gain as ...
SpaceX is charging toward a historic IPO, aiming for a mid-June pricing and a Nasdaq debut under SPCX. The deal could...
Solana leads in current on-chain activity as of mid-May 2026, with XRP showing growing throughput and Cardano lagging...
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
A Dallas-based brokerage joins Compass, expanding its footprint across Dallas–Fort Worth and Austin with a team of 10...